News

22
Oct

Somar Pharmaceutical Group: a commitment to clinical research

The commitment to innovation drives the pharmaceutical firm to continue improving lives, which is why it is working on the launch of 12 new health solutions in a period of 18 months.

18
Aug

ENDO announces sale of Grupo Farmaceutico SOMAR

Endo International plc (NASDAQ: ENDP) announced on July 5, 2017 that is signed a definitive agreement for the sale of Mexico City based Grupo Farmaceutico Somar